IGC Pharma, Inc. (IGC)
0.3308
+0.02
(+7.51%)
USD |
NYAM |
Aug 27, 16:00
0.328
0.00 (0.00%)
After-Hours: 20:00
IGC Pharma Price to Book Value : 5.525 for Aug. 27, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 26, 2026 | 5.140 |
| August 25, 2026 | 5.088 |
| August 24, 2026 | 5.021 |
| August 21, 2026 | 5.144 |
| August 20, 2026 | 4.63 |
| August 19, 2026 | 4.765 |
| August 18, 2026 | 4.750 |
| August 17, 2026 | 4.677 |
| August 14, 2026 | 4.974 |
| August 13, 2026 | 4.911 |
| August 12, 2026 | 4.775 |
| August 11, 2026 | 4.694 |
| August 10, 2026 | 4.468 |
| August 07, 2026 | 4.286 |
| August 06, 2026 | 4.174 |
| August 05, 2026 | 4.209 |
| August 04, 2026 | 4.142 |
| August 03, 2026 | 4.094 |
| July 31, 2026 | 4.159 |
| July 30, 2026 | 4.167 |
| July 29, 2026 | 4.009 |
| July 28, 2026 | 4.326 |
| July 27, 2026 | 4.393 |
| July 24, 2026 | 4.410 |
| July 23, 2026 | 4.426 |
| Date | Value |
|---|---|
| July 22, 2026 | 4.508 |
| July 21, 2026 | 4.461 |
| July 20, 2026 | 4.475 |
| July 17, 2026 | 4.343 |
| July 16, 2026 | 4.281 |
| July 15, 2026 | 4.475 |
| July 14, 2026 | 4.460 |
| July 13, 2026 | 4.441 |
| July 10, 2026 | 4.543 |
| July 09, 2026 | 4.660 |
| July 08, 2026 | 4.595 |
| July 07, 2026 | 4.643 |
| July 06, 2026 | 4.694 |
| July 02, 2026 | 4.692 |
| July 01, 2026 | 4.588 |
| June 30, 2026 | 4.543 |
| June 29, 2026 | 4.374 |
| June 26, 2026 | 4.245 |
| June 25, 2026 | 4.227 |
| June 24, 2026 | 4.332 |
| June 23, 2026 | 4.277 |
| June 22, 2026 | 4.303 |
| June 18, 2026 | 4.437 |
| June 17, 2026 | 4.450 |
| June 16, 2026 | 4.480 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cocrystal Pharma, Inc. | 15.19 |
| CNBX Pharmaceuticals, Inc. | -- |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 1.074 |
| Fulcrum Therapeutics, Inc. | 0.9465 |
Price to Book Value Related Metrics
| PS Ratio | 28.20 |
| PEG Ratio | -0.0973 |
| Price | 0.3308 |
| Earnings Yield | -24.67% |
| Market Cap | 33.88M |
| PEGY Ratio | -0.0973 |